(Q36827305)

16 August 2017

False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load (English)

1 reference

16 August 2017

1 reference

8

Jean W Pape

1 reference

16 August 2017

7

Daniel W Fitzgerald

1 reference

16 August 2017

6

Vanessa Rouzier

1 reference

16 August 2017

1

Oksana Ocheretina

1 reference

16 August 2017

Erin Byrt

2

1 reference

16 August 2017

Marie-Marcelle Mabou

series ordinal

3

1 reference

16 August 2017

Gertrude Royal-Mardi

series ordinal

4

1 reference

16 August 2017

Yves-Mary Merveille

series ordinal

5

1 reference

16 August 2017

15 January 2016

1 reference

Diagnostic Microbiology and Infectious Disease

16 August 2017

1 reference

16 August 2017

85

1 reference

16 August 2017

1

1 reference

16 August 2017

53-55

1 reference

Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Diagnostic implications of inconsistent results obtained with the Xpert MTB/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Rifampin drug resistance tests for tuberculosis: challenging the gold standard

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4841693

An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis

29 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26915638

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.DIAGMICROBIO.2016.01.009

1 reference

16 August 2017

1 reference

16 August 2017

1 reference